Analysis of Global and Absorption, Distribution, Metabolism, and Elimination Gene Expression in the Progressive Stages of Human Nonalcoholic Fatty Liver Disease
April D. Lake,Petr Novák,Petr Novák,Craig D. Fisher,Jonathan P. Jackson,Rhiannon N. Hardwick,Dean Billheimer,Walter T. Klimecki,Nathan J. Cherrington +8 more
Reads0
Chats0
TLDR
The results suggest that uptake transporter genes are coordinately targeted for down-regulation at the global level during the pathological development of NASH and that these patients may have decreased drug uptake capacity.Abstract:
Nonalcoholic fatty liver disease (NAFLD) is characterized by a series of pathological changes that range from simple fatty liver to nonalcoholic steatohepatitis (NASH). The objective of this study is to describe changes in global gene expression associated with the progression of human NAFLD. This study is focused on the expression levels of genes responsible for the absorption, distribution, metabolism, and elimination (ADME) of drugs. Differential gene expression between three clinically defined pathological groups-normal, steatosis, and NASH-was analyzed. Genome-wide mRNA levels in samples of human liver tissue were assayed with Affymetrix GeneChip Human 1.0ST arrays. A total of 11,633 genes exhibited altered expression out of 33,252 genes at a 5% false discovery rate. Most gene expression changes occurred in the progression from steatosis to NASH. Principal component analysis revealed that hepatic disease status was the major determinant of differential ADME gene expression rather than age or sex of sample donors. Among the 515 drug transporters and 258 drug-metabolizing enzymes (DMEs) examined, uptake transporters but not efflux transporters or DMEs were significantly over-represented in the number of genes down-regulated. These results suggest that uptake transporter genes are coordinately targeted for down-regulation at the global level during the pathological development of NASH and that these patients may have decreased drug uptake capacity. This coordinated regulation of uptake transporter genes is indicative of a hepatoprotective mechanism acting to prevent accumulation of toxic intermediates in disease-compromised hepatocytes.read more
Citations
More filters
Journal ArticleDOI
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
TL;DR: Recent progress on drug metabolism activity profiles, interindividual variability and regulation of expression, and the functional and clinical impact of genetic variation in drug metabolizing P450s are reviewed.
Journal ArticleDOI
Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease
TL;DR: A consensus GEM for hepatocytes is reconstructed that extends previous models by including an extensive description of lipid metabolism and it is shown that blood concentrations of chondroitin and heparan sulphates are suitable for diagnosing non-alcoholic steatohepatitis and for the staging of non- alcoholic fatty liver disease.
Journal ArticleDOI
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
D. Lee Gorden,David S. Myers,Pavlina T. Ivanova,Eoin Fahy,Mano Ram Maurya,Shakti Gupta,Jun Min,Nathanael J. Spann,Jeffrey G. McDonald,Samuel Kelly,Jingjing Duan,M. Cameron Sullards,Thomas J. Leiker,Robert M. Barkley,Oswald Quehenberger,Aaron M. Armando,Stephen B. Milne,Thomas P. Mathews,Michelle D. Armstrong,Chijun Li,Willie Melvin,Ronald H. Clements,M. Kay Washington,Alisha M. Mendonsa,Joseph L. Witztum,Ziqiang Guan,Christopher K. Glass,Robert C. Murphy,Edward A. Dennis,Alfred H. Merrill,David W. Russell,Shankar Subramaniam,H. Alex Brown +32 more
TL;DR: An “omics” approach to detecting a reproducible signature of lipid metabolites, aqueous intracellular metabolites, SNPs, and mRNA transcripts in a double-blinded study of patients with different stages of NAFLD that involves profiling liver biopsies, plasma, and urine samples is described.
Journal ArticleDOI
Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n‐3 and n‐6 polyunsaturated fatty acids
Bianca M. Arendt,Elena M. Comelli,David W.L. Ma,Wendy Lou,Anastasia Teterina,TaeHyung Kim,Scott Fung,David Wong,Ian D. McGilvray,Sandra Fischer,Johane P. Allard +10 more
TL;DR: Well‐defined subjects with either healthy liver, SS, or NASH showed distinct hepatic gene expression profiles including genes involved in unsaturated FA metabolism, and in patients with NASH, hepatic PUFAs were lower and associations with gene expression were different compared to SS.
Journal ArticleDOI
Toxicant-associated Steatohepatitis
Banrida Wahlang,Juliane I. Beier,Heather B. Clair,Heather J. Bellis-Jones,K. Cameron Falkner,Craig J. McClain,Matthew C. Cave +6 more
TL;DR: Examination of chemical exposures associated with TAFLD in human subjects or animal models and concisely reviews the closely related NAFLD and ALD are reviewed.
References
More filters
Journal ArticleDOI
Controlling the false discovery rate: a practical and powerful approach to multiple testing
Yoav Benjamini,Yosef Hochberg +1 more
TL;DR: In this paper, a different approach to problems of multiple significance testing is presented, which calls for controlling the expected proportion of falsely rejected hypotheses -the false discovery rate, which is equivalent to the FWER when all hypotheses are true but is smaller otherwise.
Journal ArticleDOI
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
David E. Kleiner,Elizabeth M. Brunt,Mark L. Van Natta,Cynthia Behling,Melissa J. Contos,Oscar W. Cummings,Linda D. Ferrell,Yao Chang Liu,Michael Torbenson,Aynur Unalp-Arida,Matthew M. Yeh,Arthur J. McCullough,Arun J. Sanyal +12 more
TL;DR: A strong scoring system and NAS for NAFLD and NASH with reasonable inter‐rater reproducibility that should be useful for studies of both adults and children with any degree ofNAFLD are presented.
Book ChapterDOI
limma: Linear Models for Microarray Data
TL;DR: This chapter starts with the simplest replicated designs and progresses through experiments with two or more groups, direct designs, factorial designs and time course experiments with technical as well as biological replication.
Journal ArticleDOI
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
TL;DR: The incidence of serious and fatal adverse drug reactions in US hospitals was found to be extremely high, and data suggest that ADRs represent an important clinical issue.
Journal ArticleDOI